MyFinsight
Home
Blog
About
Contact
Download
Download image
Locations Excluding The
United States And...
$82,072K
(15.63%↑ Y/Y)
US
$69,279K
(13.88%↑ Y/Y)
Europe
$57,304K
(28.75%↑ Y/Y)
US
$115,400K
(6.52%↑ Y/Y)
Europe
$18,348K
(20.76%↑ Y/Y)
Locations Excluding The
United States And...
$18,040K
(17.41%↑ Y/Y)
Cardiopulmonary
Segment-Operating Segments
$208,655K
(18.34%↑ Y/Y)
Neuromodulation
Segment-Operating Segments
$151,788K
(9.28%↑ Y/Y)
Corporate Non Segment
$1,815K
(10.54%↑ Y/Y)
Net revenue
$362,258K
(14.33%↑ Y/Y)
Gross profit
$243,749K
(10.41%↑ Y/Y)
Cost of sales
$118,509K
(23.34%↑ Y/Y)
Operating income
$41,471K
(-14.70%↓ Y/Y)
Selling, general, and
administrative
$143,568K
(7.41%↑ Y/Y)
Research and development
$58,695K
(54.95%↑ Y/Y)
Other operating
expense
-$15K
(97.55%↑ Y/Y)
Income (gain) before
income tax
$27,485K
(108.71%↑ Y/Y)
Interest expense
$8,291K
(-45.76%↓ Y/Y)
Foreign exchange and
other...
-$5,695K
(-149.89%↓ Y/Y)
Net income (gain)
$22,294K
(106.81%↑ Y/Y)
Income tax expense
$4,340K
(-62.77%↓ Y/Y)
Loss from equity
method investments
-$851K
(-4155.00%↓ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
LivaNova PLC (LIVN)
LivaNova PLC (LIVN)